Asep Inc. Signs Joint Venture Term Sheet with Leading Chinese Medical Diagnostic Company Sansure Biotech Inc. in Preparation for the Commercialization of the SepsetER Sepsis Diagnostic Test in China by asepadmin | Jan 27, 2023 | Uncategorized
Asep Medical Holdings Inc. Announces Adoption of Long-term Performance Incentive Plan, Grant of Stock Options by asepadmin | Jan 20, 2023 | Uncategorized
Asep Medical Holdings Inc. to Hold Important Investor Information Webinar on January 24, 2023 by asepadmin | Jan 18, 2023 | Uncategorized
Asep Inc. Signs Letter of Intent for Joint Venture with Bahrain-based Seaspring W.L.L. for Regulatory Approval and Commercialization of Sepsis Diagnosis Technology in the Kingdom of Bahrain, the Middle East and North Africa by asepadmin | Jan 6, 2023 | Uncategorized
CLARIFICATION Asep Medical Holdings Inc. Provides Update on its Prior Disclosure Regarding Proprietary Diagnostic & Therapeutic Technologies by asepadmin | Dec 28, 2022 | Uncategorized
